Corrigendum to “D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats” [Eur. J. Pharmacol. 862 (2019) 172632]
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
留言 (0)